Prosecution Insights
Prosecution Insights
18 pending office actions • 12 art units • 17 examiners • 0 of 18 (0%) have an AI response strategy ready • 32 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 18 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 18 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 1 (6%) |
| §103 only | 6 (33%) |
| §102 only | 2 (11%) |
| §112 only | 5 (28%) |
| No statute on record | 4 (22%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HA, JULIE | 2 | 75.6% | +44.4% |
| DABKOWSKI, ERINNE R | 1 | 55.8% | +69.0% |
| NAJARIAN, LENA | 1 | 38.5% | +39.6% |
| HELLMAN, KRISTINA M | 1 | 66.0% | +54.3% |
| CHANG, KYUNG SOOK | 1 | 60.3% | +41.2% |
| SZPERKA, MICHAEL EDWARD | 1 | 62.5% | +37.6% |
| CARR, DEBORAH D | 1 | 81.6% | +2.6% |
| DHAR, MATASHA | 1 | 44.7% | +50.1% |
| GONZALEZ, LEI NMN | 1 | 52.9% | +52.8% |
| HOWARD, ZACHARY C | 1 | 63.9% | +38.2% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18274614 | NOVEL SYNTHESIS OF SALCAPROZIC ACID BY AMIDE FORMATION | CARR, DEBORAH D | 10d overdue |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19310993 | SEMAGLUTIDE FOR USE IN MEDICINE | DABKOWSKI, ERINNE R | 31d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18643038 | SOLID COMPOSITIONS COMPRISING A GLP-1 AGONIST AND A SALT OF N-(8-(2-HYDROXYBENZOYL)AMINO)CAPRYLIC ACID | HELLMAN, KRISTINA M | 103d overdue |
| 18577720 | TABLET COMPRISING A SALT OF N-(8-(2-HYDROXYBENZOYL)AMINO)CAPRYLIC ACID | CHANG, KYUNG SOOK | 86d overdue |
| 19310993 | SEMAGLUTIDE FOR USE IN MEDICINE | DABKOWSKI, ERINNE R | 31d overdue |
| 18022538 | METHOD FOR SCREENING IN VITRO POPULATION OF STEM CELL DERIVED BETA LIKE CELLS AND NOVEL MARKERS THEREOF | DHAR, MATASHA | 31d overdue |
| 18017041 | CO-AGONISTS AT GLP-1 AND GIP RECEPTORS SUITABLE FOR ORAL DELIVERY | HA, JULIE | 28d overdue |
| 17598010 | GLUCOSE SENSITIVE INSULIN DERIVATIVES | HA, JULIE | 28d overdue |
| 18242868 | FACTOR X BINDERS ENHANCING FX ACTIVATION | SZPERKA, MICHAEL EDWARD | 5d overdue |
| 18020386 | INGESTIBLE DRUG DELIVERY DEVICE | GONZALEZ, LEI NMN | 26d |
| Art Unit | Apps |
|---|---|
| 1654 | 4 |
| 3783 | 3 |
| 1674 | 2 |
| 3687 | 1 |
| 1613 | 1 |
| 1641 | 1 |
| 1691 | 1 |
| 1632 | 1 |
| 1612 | 1 |
| 1657 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19310993 | SEMAGLUTIDE FOR USE IN MEDICINE | DABKOWSKI, ERINNE R | 1654 | §101 | Non-Final OA | 31d overdue | Pending | Aug 27, 2025 |
| 18730933 | SYSTEMS AND METHODS FOR PERSONALIZED INSULIN TITRATION | NAJARIAN, LENA | 3687 | §103 | Non-Final OA | 33d | Pending | Jul 22, 2024 |
| 18643038 | SOLID COMPOSITIONS COMPRISING A GLP-1 AGONIST AND A SALT OF N-(8-(2-HYDROXYBENZOYL)AMINO)CAPRYLIC ACID | HELLMAN, KRISTINA M | 1654 | Other | Non-Final OA | 103d overdue | Pending | Apr 23, 2024 |
| 18577720 | TABLET COMPRISING A SALT OF N-(8-(2-HYDROXYBENZOYL)AMINO)CAPRYLIC ACID | CHANG, KYUNG SOOK | 1613 | Other | Non-Final OA | 86d overdue | Pending | Jan 09, 2024 |
| 18242868 | FACTOR X BINDERS ENHANCING FX ACTIVATION | SZPERKA, MICHAEL EDWARD | 1641 | Other | Final Rejection | 5d overdue | Pending | Sep 06, 2023 |
| 18274614 | NOVEL SYNTHESIS OF SALCAPROZIC ACID BY AMIDE FORMATION | CARR, DEBORAH D | 1691 | §112 | Non-Final OA | 10d overdue | Pending | Jul 27, 2023 |
| 18022538 | METHOD FOR SCREENING IN VITRO POPULATION OF STEM CELL DERIVED BETA LIKE CELLS AND NOVEL MARKERS THEREOF | DHAR, MATASHA | 1632 | §102 | Non-Final OA | 31d overdue | Pending | Feb 22, 2023 |
| 18020386 | INGESTIBLE DRUG DELIVERY DEVICE | GONZALEZ, LEI NMN | 3783 | §112 | Final Rejection | 26d | Pending | Feb 08, 2023 |
| 18017041 | CO-AGONISTS AT GLP-1 AND GIP RECEPTORS SUITABLE FOR ORAL DELIVERY | HA, JULIE | 1654 | §112 | Non-Final OA | 28d overdue | Pending | Jan 19, 2023 |
| 18015444 | METHODS FOR TREATING CARDIOVASCULAR DISEASE | HOWARD, ZACHARY C | 1674 | §112 | Final Rejection | 26d | Pending | Jan 10, 2023 |
| 17800747 | GLP-1 COMPOSITIONS AND USES THEREOF | ATKINSON, JOSHUA ALEXANDER | 1612 | Other | Non-Final OA | 31d overdue | Pending | Aug 18, 2022 |
| 17833587 | METHODS FOR THE PURIFICATION OF PROTEINS USING CAPRYLIC ACID | BREEN, KIMBERLY CATHERINE | 1657 | §103 | Non-Final OA | 23d | Pending | Jun 06, 2022 |
| 17782249 | FIXED DOSE INJECTION DEVICE | GRASMEDER, SARAH DYMPNA | 3783 | §103 | Final Rejection | 11d overdue | Pending | Jun 03, 2022 |
| 17708660 | METHODS FOR TREATING IL-6 MEDIATED INFLAMMATION WITHOUT IMMUNOSUPPRESSION | CARTER, SANDRA DILLAHUNT | 1674 | §103 | Final Rejection | 34d | Pending | Mar 30, 2022 |
| 17512751 | Anti-IL-6 Antibody Formulation | BERHANE, SELAM | 1675 | §103 | Non-Final OA | 46d overdue | Pending | Oct 28, 2021 |
| 17598010 | GLUCOSE SENSITIVE INSULIN DERIVATIVES | HA, JULIE | 1654 | §102 | Non-Final OA | 28d overdue | Pending | Sep 24, 2021 |
| 17418176 | DRUG RESERVOIR FOR SEPARATE STORAGE OF SUBSTANCES | DIPERT, FORREST BLAKE | 3783 | §103 | Final Rejection | 33d | Pending | Jun 24, 2021 |
| 17270072 | SYSTEMS AND METHODS FOR PROVIDING CONTAINER BASED MEDICATION DOSE GUIDANCE TO TREAT DIABETES | ROSSI, VY BUI | 1685 | §112 | Final Rejection | 45d overdue | Pending | Feb 22, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial